title: Nutrition and benign prostatic hyperplasia.
abstract: OBJECTIVE
  Nutrition seems to modify the pathogenesis of benign prostatic hyperplasia (BPH) effect symptomology in men suffering from lower urinary tract symptoms (LUTS). Although there are numerous pharmaceuticals and procedures for these conditions, nutrition may improve outcomes as a primary approach or in tandem with BPH medications or procedures. The purpose of this review is to highlight the benefits of nutrition and dietary supplements in men with BPH and LUTS.
  
  
  RESULTS
  Dietary factors have an impact on metabolic disorders that lead to diabetes and obesity - both of which inversely effect BPH and LUTS. Dietary patterns associated with increased risks include starches and red meats, whereas moderate alcohol intake and polyunsaturated fat and vegetable consumption decrease risks. Dietary supplements of zinc, saw palmetto, and beta-sitosterol in relieving BPH symptoms have had mixed results. Randomized clinical trials of nutritional practices and other lifestyle alterations such as exercise for the prevention or treatment of BPH and LUTS have yet to be performed.
  
  
  CONCLUSIONS
  Nutritional practices may provide for the prevention and treatment of BPH and LUTS while positively affecting other systemic parameters. Whereas there are a few clinical randomized trials for the prevention and treatment of BPH and LUTS, nutritional modifications may have a healthy lifestyle alternative with minimal to no adverse effects.
authors.affiliation: Department of Urology, NYU Langone Medical Center, New York, New York, USA. geovanni.espinosa@nyumc.org
authors.forename: Geovanni
authors.initials: G
authors.lastname: Espinosa
mesh_terms: D019587:Dietary Supplements; D006801:Humans; D008019:Life Style; D059411:Lower Urinary Tract Symptoms / Q000178:diet therapy / Q000517:prevention & control; D008297:Male; D044623:Nutrition Therapy; D010936:Plant Extracts / Q000627:therapeutic use; D011470:Prostatic Hyperplasia / Q000178:diet therapy* / Q000517:prevention & control*; D012434:Secale; D012855:Sitosterols / Q000627:therapeutic use
chemical_list: D010936:Plant Extracts; D012855:Sitosterols; C025473:gamma-sitosterol; C010070:cernilton